OptraSCAN® Launches BactoSiA™, Bringing AI-Enabled Standardization to TB Smear Microscopy
recent articles
Owkin to collaborate with MSD to develop and commercialize AI-powered digital pathology Microsatellite Instability High (MSI-H) diagnostics for four types of cancer. The aim is to pre-screen patients for the MSI-H biomarker, which is found...
Driving Quality and Efficiency in Digital Pathology Workflows with AI-Enabled Tumor Assessment Boston, MA – December 14, 2023 – PathAI, a global leader in AI-powered pathology, today announced TumorDetect on AISightTM, PathAI’s...
Concord, MA (12/14/2023) – Corista, a leader in digital pathology solutions, announced its DP3 platform has been certified with the CE In Vitro Diagnostic (IVDR) marking, for routine diagnosis in the European Union and United Kingdom. The CE...
As I mentioned about 6 months ago, our practice has adopted the use of digital pathology. While it is "digital", it is simply, pathology. At least 80% of my caseload is now viewed on a monitor. The work is done with mouse rather than...
From LinkedIn: Congratulations to the entire Deciphex team on our double win at the Irish Medtech Awards! 🎉 We're absolutely thrilled to have been named Medtech Company of the Year and to receive the Digital Health Innovation of the Year...
UF Research results call into question the safety and dependability of using artificial intelligence in medical diagnosis, a development that should be watched by clinical laboratory scientists ChatGPT, an artificial...
